Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: Comparison with sister chromatid exchange frequency

International Archives of Occupational and Environmental Health

Volumn 72, Issue 5, 1999, Pages 315-322

  Lanza, A ^a   Cuna, F S Robustelli Della ^a   Zibera, C ^a   Pedrazzoli, P ^a   Cuna, G Robustelli Delta ^a  

^a IRCCS   (Italy)

Author keywords

Antineoplastic agents; Occupational exposure; Sister chromatid exchange; Somatic mutation; T cell receptor gene

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CANCER PATIENT; CHEMOTHERAPY; CIGARETTE SMOKING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; DRUG CARCINOGENICITY; DRUG MEGADOSE; FEMALE; GENE LOCUS; GENETICS; HUMAN; HUMAN TISSUE; MALE; MONONUCLEAR CELL; MUTATION RATE; NURSE; OCCUPATIONAL EXPOSURE; SISTER CHROMATID EXCHANGE; SOMATIC MUTATION; STEM CELL;

ADULT; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARCINOGENS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, T-CELL RECEPTOR; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; NURSES; OCCUPATIONAL EXPOSURE; SISTER CHROMATID EXCHANGE; SMOKING;

EID: 0345425029     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004200050381     Document Type: Article

References (42)

1. Akiyama M, Kyoizumi S, Hirai Y, Kusunoki Y, Iwamoto KS, Nakamura N (1995) Mutation frequency in human blood cells increases with age. Mutat Res 338: 141-149
2. Albertini RJ, Castle KL, Borcherding WR (1982) T-cell cloning to detect the mutant 6-thioguanine resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci USA 79: 6617-6621
3. Baker ES, Connor TH (1996) Monitoring occupational exposure to cancer chemotherapy. Am J Health Syst Pharm 53: 2713-2723
4. Barale R, Sozzi G, Toniolo P, Borghi O, Reali D, Loprieno N, Della Porta G (1985) Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs. Mutat Res 157: 235-240
5. Bigbee WL, Wyrobek AJ, Langlois RG, Jensen RH, Everson RB (1990) The effect of chemotherapy on the in vivo frequency of glycophorin A "null" variant erytrocytes. Mutat Res 240: 165-175
6. Bos RP, Sessink PJ (1997) Biomonitoring of occupational exposures to cytostatic anticancer drugs. Rev Environ Health 12: 43-58
7. Branda RF, O'Neill JP, Sullivan LM, Albertini RJ (1991) Factors influencing the hprt locus in T-lymphocytes: women treated for breast cancer. Cancer Res 51: 6603-6607
8. Chrisostomou A, Seshadri RS, Morley AA (1984) Mutation frequency in nurses and pharmacists exposed to cytostatic drugs. Aust NZ J Med 14: 831-834
9. Dempsey J, Seshadri RS, Morley AA (1985) Increased mutation frequency following treatment with cancer chemotherapy. Cancer Res 45: 2873-2877
10. Dhillon VS, Bhasker R, Kler RS, Husain SA (1995) Sister chromatid exchange (SCE) studies in breast cancer patients: a follow up study. Cancer Genet Cytogenet 80: 115-117
11. Dubeau H, Zazi W, Baron C, Messing K (1994) Effects of lymphocyte subpopulations on the clonal assay of HPRT mutants: occupational exposure to cytostatic drugs. Mutat Res 321: 147-157
12. Ensslin AS, Huber R, Pethran A, Rommelt H, Schierl R, Kulka U, Fruhmann G (1997) Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies. Int Arch Occup Environ Health 70: 205-208
13. Fucic A, Jazbec A, Mijic A, Seso-Simic D, Tomek R (1998) Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutarc;t Res 416: 59-66
14. Hagmar L, Bonassi S, Stronberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brogger A, Forni A, Hogstedt B, Lambert B, Mitelman F, Norderson I, Salomaa S, Skerfving S (1998) Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat Res 405: 171-178
15. Hanawalt PC, Sarasin A (1986) Cancer-prone hereditary diseases with DNA processing abnormalities. Trends Genet 2: 124-129
16. Hirota H, Kubota S, Adachi S, Okuda A, Lin YW, Bessho R, Wakazono Y, Matsubara K, Kuwakado K, Akiyama Y, Tsutsui T (1994) Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation. Mutat Res 315: 95-103
17. Husain SA, Bamezai R (1988) Sister chromatid exchange (SCE) rate in normal and abnormal sexual development in males and females. Mutat Res 206: 261-270
18. Husain SA, Balasubramanian S, Bamezai R (1992) Sister chromatid exchange frequency in breast cancer cases. Cancer Genet Cytogenet 61: 142-146
19. Husum B, Wulf HC, Niebuhr E (1981) Sister-chromatic exchanges in lymphocytes in women with cancer of the breast. Mutat Res 85: 357-362
20. Jonatipour M, Trainor KJ, Kutlaca G, Bennett G, Hay J, Turner DR, Morley AA (1988) Mutations in human lymphocytes studied by an HLA selection system. Mutat Res 198: 221-226
21. Kelsey KT, Wiencke JK, Eisen EA, Lynch DW, Lewis TR, Little JB (1988) Persistently elevated sister chromatid exchanges in ethylene oxide-exposed primates: the role of a subpopulation of high frequency cells. Cancer Res 48: 5045-5050
22. + T cells. J Exp Med 171: 1981-1999
23. Kyoizumi S, Umeki S, Akiyama M, Hirai Y, Kusunoki Y, Najamura N, Endoh K, Konishi J, Sasaki MS, Mori T, Fujita S, Cologne JB (1992) Frequency of mutant T lymphocytes defective in the expression of the T-cell antigen receptor gene among radiation-exposed people. Mutat Res 265: 173-180
24. Lambert B, Bredberg A, McKenzie W, Sten M (1982) Sister chromatid exchange in human populations: the effect of smoking, drug treatment, and occupational exposure. Cytogenet Cell Genet 33: 62-67
25. Langlois RG, Nisbet BA, Bigbee WL, Ridinger DN, Jensen RH (1990) An improved flow cytometric assay for somatic mutations at the glycophorin A locus in humans Cytometry 11: 513-521
26. Livingston GK, Cannon LA, Bishop DT, Johnson P, Fineman RM (1983) Sister chromatid exchange: variation by age, sex, smoking, and breast cancer status. Cancer Genet Cytogenet 9: 289-299
27. Malcolm AS, McCaffrey RP, Karp JE (1996) The secondary leukemias: challenges and research directions. J Natl Cancer Inst 88: 407-418
28. Mei N, Kunugita N, Nomoto S, Norimura T (1996) Comparison of the frequency of T-cell receptor mutants and thioguanine resistance induced by X-rays and ethylnitrosurea in cultured human blood T-lymphocytes. Mutat Res 357: 191-197
29. Messing K, Bradley WEC (1985) In vivo mutant frequency rises among breast cancer patients after exposure to high doses of y-radiation. Mutat Res 152: 107-112
30. Pearson PL, Van der Luijt RB (1998) The genetic analysis of cancer. J Intern Med 243: 413-417
31. Perry P, Wolff S (1974) New Giemsa method for the differential staining of sister chromatids. Nature 251: 156-158
32. Ponzanelli I, Landi S, Bernacchi F, Barale R (1997) The nature of high frequency sister chromatid exchange cells (HFCs). Mutagenesis 12: 329-333
33. Roth S, Norppa H, Jarventaus H, Kyyronen P, Ahonen M, Lehtomaki J, Sainio H, Sorsa M (1994) Analysis of chromosomal aberrations, sister-chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs. Mutat Res 325: 157-162
34. Sawada M, Kubota M, Lin YW, Watanabe K, Koishi S, Usami I, Akiyama Y, Matsamura T, Furosho K. (1998) Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment. Mutat Res 397: 337-343
35. Skov T (1993) Handling antineoplastic drugs in the European Community countries. European J Cancer Prev 2: 43-46
36. Sorsa M, Anderson D (1996) Monitoring of occupational exposure to cytostatic anticancer. Mutat Res 253: 253-261
37. Sorsa M, Hemmink K, Vainio H (1985) Occupational exposure to anticancer drugs. Potenzial and real hazards. Mutat Res 154: 135-149
38. Tales AD, Grummt T, van Dam FJ, de Zwart F, Kasper FJ, Rothe R, Stirn H, Zwinderman AH, Natarajan AT (1994) Measurement of frequencies of HPRT mutants, chromosomal aberrations, micronuclei, sister-chromatid exchanges and cells with high frequencies of SCEs in styrene/dichloromethane-exposed workers. Mutat Res 313: 249-262
39. Umeki S, Kyoizumi S, Kusunoki Y, Nakamura N, Sasaki M, Mori T, Ishikawa Y, Cologne JB, Akiyama M (1991) Flow cytometric measurements of somatic cell mutations in Thorotrast patients. Jpn J Cancer Res 82: 1349-1353
40. Valagussa P, Bonadonna G (1998) Hodgkin's disease and the risk of acute leukemia in successfully treated patients. Haematologica 83: 769-770
41. Valanis B, Vollmer W, Labuhn K, Glass A (1997) Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J Occup Environ Med 39: 574-580
42. Vereantern P, Maulapas E, Viietink R, Cassiman JJ, Vanden Berghe H (1986) Non uniform distribution of sister chromatid exchanges in human lymphocytes. Chromosoma 93: 197-202